H. Mutunzi

Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert(®) MTB/RIF in Zimbabwe.

A. Harries, P. Owiti, P. Chonzi, 2016, Public health action.

Prevalence, risk factors and treatment outcomes of isoniazid resistant TB in Bulawayo city, Zimbabwe: A cohort study

P. Thekkur, J. Dzangare, D. Mangwanya, 2020, Journal of infection in developing countries.

How has the Zimbabwe mycobacterial culture and drug sensitivity testing system among re-treatment tuberculosis patients functioned during the scale-up of the Xpert MTB/RIF assay?

A. Harries, K. Takarinda, Ajay M. V. Kumar, 2018, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey

J. Metcalfe, N. Kalisvaart, J. Chirenda, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Preparing national tuberculosis control programmes for COVID-19.

A. Harries, K. Takarinda, R. Dlodlo, 2020, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.